Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
|
Mol Cancer Ther
|
2009
|
2.41
|
2
|
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
|
Surgery
|
2011
|
2.06
|
3
|
alpha-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma.
|
Pancreas
|
2010
|
1.94
|
4
|
MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation.
|
Mol Cancer
|
2010
|
1.66
|
5
|
Intraabdominal Roux-en-Y reconstruction with a novel stapling technique after laparoscopic distal gastrectomy.
|
Gastric Cancer
|
2009
|
1.54
|
6
|
Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.
|
Neoplasia
|
2010
|
1.36
|
7
|
CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
|
Gastroenterology
|
2010
|
1.33
|
8
|
Effectiveness of basic endoscopic surgical skill training for pediatric surgeons.
|
Pediatr Surg Int
|
2010
|
1.27
|
9
|
MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
|
Ann Surg Oncol
|
2010
|
1.25
|
10
|
MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
|
Cancer Biol Ther
|
2010
|
1.17
|
11
|
Laparoscopy-assisted distal gastrectomy for early gastric cancer: is it beneficial for patients of heavier weight?
|
Ann Surg
|
2003
|
1.11
|
12
|
Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.
|
Cancer Sci
|
2008
|
1.08
|
13
|
Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer.
|
Anticancer Res
|
2008
|
1.06
|
14
|
Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
|
Cancer Res
|
2013
|
1.06
|
15
|
Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells.
|
Cancer
|
2010
|
1.05
|
16
|
Feasibility and safety of intracorporeal esophagojejunostomy after laparoscopic total gastrectomy: inverted T-shaped anastomosis using linear staplers.
|
Surgery
|
2013
|
1.02
|
17
|
Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer.
|
Cancer Sci
|
2011
|
1.01
|
18
|
Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells.
|
Cancer Sci
|
2009
|
1.01
|
19
|
Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
|
Hum Pathol
|
2010
|
1.00
|
20
|
Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
|
Ann Surg
|
2013
|
0.98
|
21
|
Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas.
|
Mol Cancer
|
2013
|
0.98
|
22
|
High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.
|
Int J Oncol
|
2011
|
0.97
|
23
|
MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma.
|
JOP
|
2010
|
0.96
|
24
|
LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.
|
Neoplasia
|
2009
|
0.96
|
25
|
Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
|
Surgery
|
2010
|
0.96
|
26
|
Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer.
|
World J Gastroenterol
|
2006
|
0.95
|
27
|
LIM only 4 is overexpressed in late stage pancreas cancer.
|
Mol Cancer
|
2008
|
0.94
|
28
|
Three-dimensional high-definition neuroendoscopic surgery: a controlled comparative laboratory study with two-dimensional endoscopy and clinical application.
|
J Neurol Surg A Cent Eur Neurosurg
|
2013
|
0.93
|
29
|
S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma.
|
J Gastrointest Surg
|
2009
|
0.93
|
30
|
Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.
|
PLoS One
|
2010
|
0.92
|
31
|
S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
|
Hum Pathol
|
2010
|
0.91
|
32
|
Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade.
|
Mod Pathol
|
2007
|
0.90
|
33
|
Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil.
|
Int J Oncol
|
2011
|
0.90
|
34
|
Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production.
|
Cancer Lett
|
2003
|
0.90
|
35
|
Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer.
|
Anticancer Res
|
2007
|
0.90
|
36
|
TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.90
|
37
|
All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells.
|
Cancer Lett
|
2004
|
0.89
|
38
|
SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
|
Anticancer Res
|
2010
|
0.89
|
39
|
Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
|
Ann Surg
|
2014
|
0.88
|
40
|
Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition.
|
PLoS One
|
2012
|
0.88
|
41
|
Laparoscopic total gastrectomy for remnant gastric cancer: feasibility study.
|
Surg Endosc
|
2013
|
0.88
|
42
|
Skills assessment using a virtual reality simulator, LapSim, after training to develop fundamental skills for endoscopic surgery.
|
Minim Invasive Ther Allied Technol
|
2010
|
0.88
|
43
|
Single-incision laparoscopy-assisted surgery for bowel obstruction: report of three cases.
|
Surg Today
|
2011
|
0.88
|
44
|
Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
|
Ann Surg Oncol
|
2011
|
0.87
|
45
|
Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
|
Int J Cancer
|
2005
|
0.87
|
46
|
Objective assessment of the suture ligature method for the laparoscopic intestinal anastomosis model using a new computerized system.
|
Surg Endosc
|
2014
|
0.87
|
47
|
Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor.
|
J Surg Res
|
2012
|
0.86
|
48
|
Bone marrow-derived monocyte lineage cells recruited by MIP-1β promote physiological revascularization in mouse model of oxygen-induced retinopathy.
|
Lab Invest
|
2011
|
0.86
|
49
|
Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis.
|
Pancreas
|
2011
|
0.85
|
50
|
The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas.
|
Clin Cancer Res
|
2007
|
0.85
|
51
|
Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes.
|
Surg Endosc
|
2014
|
0.85
|
52
|
Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer.
|
Cancer Lett
|
2010
|
0.84
|
53
|
Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion.
|
Ann Surg Oncol
|
2014
|
0.84
|
54
|
Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
|
Clin Cancer Res
|
2008
|
0.83
|
55
|
An augmented reality navigation system for pediatric oncologic surgery based on preoperative CT and MRI images.
|
J Pediatr Surg
|
2013
|
0.82
|
56
|
Kindlin-2 expression in peritumoral stroma is associated with poor prognosis in pancreatic ductal adenocarcinoma.
|
Pancreas
|
2013
|
0.82
|
57
|
Kindlin-1 expression is involved in migration and invasion of pancreatic cancer.
|
Int J Oncol
|
2013
|
0.82
|
58
|
Feasibility of laparoscopic gastrectomy for advanced gastric cancer with positive peritoneal cytology.
|
Surg Today
|
2012
|
0.81
|
59
|
Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells.
|
Anticancer Res
|
2011
|
0.81
|
60
|
Midkine mRNA is overexpressed in pancreatic cancer.
|
Dig Dis Sci
|
2008
|
0.81
|
61
|
Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens.
|
Cancer Sci
|
2008
|
0.81
|
62
|
Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway.
|
Cancer Sci
|
2010
|
0.81
|
63
|
Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
|
Pancreas
|
2015
|
0.81
|
64
|
REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms.
|
Mod Pathol
|
2009
|
0.81
|
65
|
Mass spectrometry-based metabolic profiling of gemcitabine-sensitive and gemcitabine-resistant pancreatic cancer cells.
|
Pancreas
|
2014
|
0.81
|
66
|
Augmented reality navigation system for laparoscopic splenectomy in children based on preoperative CT image using optical tracking device.
|
Pediatr Surg Int
|
2011
|
0.81
|
67
|
Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model.
|
Surgery
|
2006
|
0.81
|
68
|
The risk of lymph node metastasis in mucosal gastric carcinoma: especially for a mixture of differentiated and undifferentiated adenocarcinoma.
|
Hepatogastroenterology
|
2012
|
0.80
|
69
|
MAL2 expression predicts distant metastasis and short survival in pancreatic cancer.
|
Surgery
|
2013
|
0.80
|
70
|
S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells.
|
Oncol Rep
|
2013
|
0.80
|
71
|
Biological evaluation of protein nanocapsules containing doxorubicin.
|
Int J Nanomedicine
|
2013
|
0.79
|
72
|
Migratory activity of CD105+ pancreatic cancer cells is strongly enhanced by pancreatic stellate cells.
|
Pancreas
|
2013
|
0.79
|
73
|
Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages.
|
Int J Nanomedicine
|
2012
|
0.79
|
74
|
CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells.
|
PLoS One
|
2012
|
0.79
|
75
|
Tissue tablet method: an efficient tissue banking procedure applicable to both molecular analysis and frozen tissue microarray.
|
Hum Pathol
|
2014
|
0.79
|
76
|
Outcomes of cervical end-to-side triangulating esophagogastric anastomosis with minimally invasive esophagectomy.
|
World J Surg
|
2015
|
0.79
|
77
|
Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1.
|
Mol Pharm
|
2015
|
0.79
|
78
|
Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.
|
Cancer Sci
|
2009
|
0.78
|
79
|
hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells.
|
Cancer Sci
|
2009
|
0.78
|
80
|
Significance of metacognitive skills in laparoscopic surgery assessed by essential task simulation.
|
Minim Invasive Ther Allied Technol
|
2013
|
0.78
|
81
|
CD44v6 expression in intraductal papillary mucinous neoplasms of the pancreas.
|
Pancreas
|
2010
|
0.77
|
82
|
Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer.
|
Ann Surg Oncol
|
2011
|
0.77
|
83
|
Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas.
|
Mod Pathol
|
2010
|
0.77
|
84
|
Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy.
|
Cancer Sci
|
2009
|
0.76
|
85
|
A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice.
|
Pancreas
|
2013
|
0.76
|
86
|
Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.
|
Histopathology
|
2011
|
0.76
|
87
|
Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia.
|
Cancer Sci
|
2011
|
0.76
|
88
|
Podoplanin expression in the cyst wall correlates with the progression of intraductal papillary mucinous neoplasm.
|
Virchows Arch
|
2014
|
0.76
|
89
|
Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
|
Pancreas
|
2016
|
0.76
|
90
|
Expression of glucagon-like Peptide 1 receptor and its effects on biologic behavior in pancreatic neuroendocrine tumors.
|
Pancreas
|
2014
|
0.75
|
91
|
[Molecular biology-based diagnosis and therapy for pancreatic cancer].
|
Fukuoka Igaku Zasshi
|
2011
|
0.75
|
92
|
Senescence in intraductal papillary mucinous neoplasm of the pancreas.
|
Hum Pathol
|
2011
|
0.75
|
93
|
S100P in Duodenal Fluid Is a Useful Diagnostic Marker for Pancreatic Ductal Adenocarcinoma.
|
Pancreas
|
2017
|
0.75
|